A recent review by Lasgari et al., suggested that statins seem to have favorable effects on inflammatory, malignant and neurodegenerative diseases by inhibiting the mammalian target of rapamycin (mTOR) pathway [32]. The gene discussed is MTOR; the disease is neurodegenerative disease.